GIRANCITUG
UNII 9AB5PRA7TP

Substance Identification & Data

This profile provides standardized clinical and technical data for Girancitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9AB5PRA7TP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3024821-77-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9AB5PRA7TP
CAS Registry Number
3024821-77-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GIRANCITUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13804
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Girancitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GIRANCITUG

Common Names & Synonyms

GIRANCITUG [INN]
H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-446) (VH (HOMO SAPIENS IGHV3-21*01 (99.0%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT (8.8.9) (26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (93.7%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)/DHFR- CELL LINE LACKING THE ENZYME DIHYDROFOLATE REDUCTASE (DHFR), GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL BC001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BC001 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS KDR (KINASE INSERT DOMAIN RECEPTOR, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2, VEGFR2, VEGF-R2, FLK1, CD309)), HOMO SAPIENS MONOCLONAL ANTIBODY (GIRANCITUG)